Company · CIK 0001093557 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
DEXCOM INC · DXCM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2016 SForm 4 → | Nov 28, 7:27 pm EST | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 10,300 | $70.32 | $724,260 | 110,409 | −8.53% | plan? |
| Nov 9, 2016 DForm 4 → | Nov 14, 6:32 pm EST | Terrance H GreggExecutive Chairman, Director | 2,172 | $62.17 | $135,042 | 444,944 | — | plan? late |
| Nov 9, 2016 SForm 4 → | Nov 14, 6:31 pm EST | John ListerGeneral Manager, EMEA | 3,417 | $62.50 | $213,563 | 70,598 | −4.62% | plan? late |
| Oct 24, 2016 SForm 4 → | Oct 26, 5:08 pm EDT | Jess RoperSVP, CFO | 2,471 | $80.75 | $199,544 | 74,215 | −3.22% | plan? |
| Oct 24, 2016 SForm 4 → | Oct 26, 5:08 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 10,300 | $81.95 | $844,065 | 120,709 | −7.86% | plan? |
| Oct 24, 2016 SForm 4 → | Oct 26, 5:07 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $81.12 | $258,110 | 25,461 | −11.1% | plan? |
| Oct 19, 2016 SForm 4 → | Oct 20, 7:55 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 4,997 | $82.31 | $411,303 | 106,345 | −4.49% | plan? |
| Oct 14, 2016 SForm 4 → | Oct 17, 8:25 pm EDT | Kevin R SayerPresident & CEO, Director | 7,000 | $81.87 | $573,101 | 299,891 | −2.28% | plan? |
| Oct 10, 2016 SForm 4 → | Oct 12, 8:59 pm EDT | John ListerGeneral Manager, EMEA | 3,560 | $84.41 | $300,508 | 74,015 | −4.59% | plan? |
| Oct 10, 2016 SForm 4 → | Oct 12, 8:57 pm EDT | Jorge A ValdesCTO | 11,000 | $84.42 | $928,579 | 72,334 | −13.2% | plan? |
| Oct 10, 2016 MForm 4 → | Oct 12, 8:57 pm EDT | Jorge A ValdesCTO | 11,000 | $7.63 | $83,930 | 83,334 | — | plan? |
| Oct 10, 2016 DForm 4 → | Oct 12, 8:56 pm EDT | Terrance H GreggExecutive Chairman, Director | 2,167 | $83.35 | $180,619 | 447,116 | — | plan? |
| Oct 5, 2016 SForm 4 → | Oct 7, 5:10 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $82.55 | $412,750 | 111,342 | −4.30% | plan? |
| Sep 23, 2016 SForm 4 → | Sep 27, 8:15 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 10,300 | $94.00 | $968,196 | 131,009 | −7.29% | plan? |
| Sep 23, 2016 SForm 4 → | Sep 27, 8:14 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $93.97 | $299,000 | 28,643 | −10.00% | plan? |
| Sep 22, 2016 SForm 4 → | Sep 23, 7:52 pm EDT | Jess RoperSVP, CFO | 2,470 | $93.99 | $232,155 | 76,686 | −3.12% | plan? |
| Sep 21, 2016 SForm 4 → | Sep 22, 6:38 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $92.87 | $464,366 | 116,342 | −4.12% | plan? |
| Sep 14, 2016 SForm 4 → | Sep 16, 5:35 pm EDT | Kevin R SayerPresident & CEO, Director | 7,000 | $91.79 | $642,527 | 306,891 | −2.23% | plan? |
| Sep 13, 2016 GForm 4 → | Sep 22, 6:37 pm EDT | Jeffrey MoySVP, Operations | 290 | — | — | 50,556 | — | plan? late |
| Sep 12, 2016 SForm 4 → | Sep 14, 8:46 pm EDT | Jay S SkylerDirector | 10,000 | $93.00 | $930,000 | 0 | −100% | plan? |
| Sep 9, 2016 SForm 4 → | Sep 13, 8:51 pm EDT | Jay S SkylerDirector | 25,000 | $94.07 | $2,351,788 | 17,246 | −59.2% | plan? |
| Sep 9, 2016 DForm 4 → | Sep 13, 8:33 pm EDT | John ListerGeneral Manager, EMEA | 9,639 | $93.72 | $903,393 | 77,575 | — | plan? |
| Sep 9, 2016 SForm 4 → | Sep 13, 8:33 pm EDT | John ListerGeneral Manager, EMEA | 3,560 | $93.65 | $333,392 | 87,214 | −3.92% | plan? |
| Sep 9, 2016 DForm 4 → | Sep 13, 8:33 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 8,668 | $93.72 | $812,388 | 83,582 | — | plan? |
| Sep 9, 2016 DForm 4 → | Sep 13, 8:33 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 10,313 | $93.72 | $966,561 | 141,309 | — | plan? |
| Sep 9, 2016 DForm 4 → | Sep 13, 8:32 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 8,668 | $93.72 | $812,387 | 121,342 | — | plan? |
| Sep 9, 2016 DForm 4 → | Sep 13, 8:32 pm EDT | John ListerGeneral Manager, EMEA | 9,639 | $93.72 | $903,393 | 77,575 | — | plan? |
| Sep 9, 2016 SForm 4 → | Sep 13, 8:32 pm EDT | John ListerGeneral Manager, EMEA | 3,560 | $93.65 | $333,392 | 87,214 | −3.92% | plan? |
| Sep 9, 2016 DForm 4 → | Sep 13, 8:31 pm EDT | Jess RoperSVP, CFO | 6,223 | $93.72 | $583,236 | 79,156 | — | plan? |
| Sep 9, 2016 DJForm 4 → | Sep 13, 8:31 pm EDT | Jeffrey MoySVP, Operations | 37,999 | $90.10 | $3,423,704 | 50,846 | — | plan? |
| Sep 9, 2016 SForm 4 → | Sep 13, 8:30 pm EDT | Jorge A ValdesCTO | 19,071 | $93.07 | $1,774,874 | 3,499 | −84.5% | plan? |
| Sep 9, 2016 DJMForm 4 → | Sep 13, 8:30 pm EDT | Jorge A ValdesCTO | 60,979 | $78.10 | $4,762,325 | 10,570 | — | plan? |
| Sep 9, 2016 DForm 4 → | Sep 13, 8:30 pm EDT | Kevin R SayerPresident & CEO, Director | 21,336 | $93.72 | $1,999,665 | 313,891 | — | plan? |
| Sep 9, 2016 DForm 4 → | Sep 13, 8:29 pm EDT | Terrance H GreggExecutive Chairman, Director | 2,203 | $93.72 | $206,471 | 449,283 | — | plan? |
| Sep 7, 2016 SForm 4 → | Sep 9, 8:50 pm EDT | Mark G FolettaDirector | 1,800 | $94.63 | $170,325 | 15,643 | −10.3% | plan? |
| Sep 7, 2016 SForm 4 → | Sep 9, 8:49 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 4,999 | $94.45 | $472,156 | 130,010 | −3.70% | plan? |
| Sep 7, 2016 MForm 4 → | Sep 9, 8:49 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 4,999 | $3.19 | $15,947 | 135,009 | — | plan? |
| Sep 7, 2016 SForm 4 → | Sep 9, 8:48 pm EDT | Terrance H GreggExecutive Chairman, Director | 10,740 | $95.29 | $1,023,400 | 65,882 | −14.0% | plan? |
| Sep 1, 2016 SForm 4 → | Sep 6, 7:34 pm EDT | Jonathan T Lord M.D.Director | 10,000 | $91.50 | $915,000 | 52,820 | −15.9% | plan? |
| Aug 30, 2016 SForm 4 → | Sep 1, 8:05 pm EDT | Terrance H GreggExecutive Chairman, Director | 10,000 | $92.14 | $921,356 | 76,622 | −11.5% | plan? |
| Aug 24, 2016 SForm 4 → | Aug 26, 6:36 pm EDT | Terrance H GreggExecutive Chairman, Director | 10,000 | $92.72 | $927,151 | 86,622 | −10.3% | plan? |
| Aug 24, 2016 SForm 4 → | Aug 26, 4:49 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $91.72 | $458,600 | 129,979 | −3.70% | plan? |
| Aug 24, 2016 MForm 4 → | Aug 26, 4:49 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $3.19 | $15,950 | 134,979 | — | plan? |
| Aug 23, 2016 SForm 4 → | Aug 25, 4:35 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $90.89 | $289,224 | 31,825 | −9.09% | plan? |
| Aug 23, 2016 SForm 4 → | Aug 25, 4:33 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 10,300 | $90.74 | $934,588 | 151,622 | −6.36% | plan? |
| Aug 22, 2016 SForm 4 → | Aug 24, 8:07 pm EDT | Terrance H GreggExecutive Chairman, Director | 20,000 | $90.81 | $1,816,223 | 96,622 | −17.1% | plan? |
| Aug 19, 2016 SForm 4 → | Aug 23, 8:35 pm EDT | Steven R AltmanDirector | 3,500 | $90.91 | $318,177 | 15,142 | −18.8% | plan? |
| Aug 19, 2016 SForm 4 → | Aug 22, 9:27 pm EDT | Jay S SkylerDirector | 25,000 | $90.77 | $2,269,233 | 42,246 | −37.2% | plan? |
| Aug 18, 2016 SForm 4 → | Aug 22, 9:26 pm EDT | Terrance H GreggExecutive Chairman, Director | 40,000 | $90.70 | $3,627,842 | 116,622 | −25.5% | plan? |
| Aug 15, 2016 SForm 4 → | Aug 17, 7:31 pm EDT | Kevin R SayerPresident & CEO, Director | 7,000 | $90.78 | $635,473 | 335,227 | −2.05% | plan? |
| Aug 15, 2016 SForm 4 → | Aug 17, 7:31 pm EDT | Terrance H GreggExecutive Chairman, Director | 14,942 | $91.01 | $1,359,858 | 156,622 | −8.71% | plan? |
| Aug 11, 2016 SForm 4 → | Aug 15, 7:50 pm EDT | Jonathan T Lord M.D.Director | 10,000 | $90.64 | $906,399 | 126,373 | −7.33% | plan? |
| Aug 11, 2016 SForm 4 → | Aug 15, 7:49 pm EDT | Terrance H GreggExecutive Chairman, Director | 10,900 | $91.03 | $992,280 | 171,564 | −5.97% | plan? |
| Aug 10, 2016 SForm 4 → | Aug 12, 7:10 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $90.26 | $451,300 | 129,979 | −3.70% | plan? |
| Aug 10, 2016 MForm 4 → | Aug 12, 7:10 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $3.19 | $15,950 | 134,979 | — | plan? |
| Aug 9, 2016 SForm 4 → | Aug 11, 9:21 pm EDT | Terrance H GreggExecutive Chairman, Director | 37,168 | $91.10 | $3,385,911 | 182,464 | −16.9% | plan? |
| Aug 9, 2016 SForm 4 → | Aug 11, 7:30 pm EDT | John ListerGeneral Manager, EMEA | 3,560 | $91.07 | $324,217 | 90,774 | −3.77% | plan? |
| Aug 9, 2016 SForm 4 → | Aug 11, 7:29 pm EDT | Jorge A ValdesCTO | 32,000 | $91.06 | $2,913,978 | 91,667 | −25.9% | plan? |
| Aug 9, 2016 MForm 4 → | Aug 11, 7:29 pm EDT | Jorge A ValdesCTO | 32,000 | $7.63 | $244,160 | 123,667 | — | plan? |
| Aug 9, 2016 SForm 4 → | Aug 11, 7:29 pm EDT | Kevin R SayerPresident & CEO, Director | 20,000 | $90.98 | $1,819,552 | 342,227 | −5.52% | plan? |
| Aug 9, 2016 MForm 4 → | Aug 11, 7:29 pm EDT | Kevin R SayerPresident & CEO, Director | 20,000 | $8.79 | $175,800 | 362,227 | — | plan? |
| Aug 8, 2016 SForm 4 → | Aug 10, 9:25 pm EDT | Barbara KahnDirector | 6,000 | $90.52 | $543,131 | 29,304 | −17.0% | plan? |
| Aug 8, 2016 MForm 4 → | Aug 9, 9:27 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 4 | $11.33 | $45 | 161,922 | — | plan? |
| Aug 5, 2016 SForm 4 → | Aug 9, 9:26 pm EDT | Jorge A ValdesCTO | 25,000 | $91.22 | $2,280,375 | 91,667 | −21.4% | plan? |
| Aug 5, 2016 MForm 4 → | Aug 9, 9:26 pm EDT | Jorge A ValdesCTO | 25,000 | $9.80 | $245,000 | 116,667 | — | plan? |
| Jul 29, 2016 SForm 4 → | Aug 2, 8:35 pm EDT | Jeffrey MoySVP, Operations | 15,000 | $92.33 | $1,385,000 | 12,599 | −54.3% | plan? |
| Jul 27, 2016 SForm 4 → | Jul 28, 8:20 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $88.14 | $440,700 | 129,979 | −3.70% | plan? |
| Jul 27, 2016 MForm 4 → | Jul 28, 8:20 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $3.19 | $15,950 | 134,979 | — | plan? |
| Jul 25, 2016 SForm 4 → | Jul 26, 7:03 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 10,300 | $87.33 | $899,473 | 161,918 | −5.98% | plan? |
| Jul 25, 2016 SForm 4 → | Jul 26, 7:02 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $87.31 | $277,822 | 35,007 | −8.33% | plan? |
| Jul 22, 2016 SForm 4 → | Jul 26, 7:03 pm EDT | Jeffrey MoySVP, Operations | 10,000 | $88.48 | $884,800 | 27,599 | −26.6% | plan? |
| Jul 19, 2016 SForm 4 → | Jul 21, 7:12 pm EDT | Jeffrey MoySVP, Operations | 12,843 | $83.78 | $1,075,969 | 37,599 | −25.5% | plan? |
| Jul 13, 2016 SForm 4 → | Jul 14, 5:17 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $80.12 | $400,600 | 129,979 | −3.70% | plan? |
| Jul 13, 2016 MForm 4 → | Jul 14, 5:17 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $3.19 | $15,950 | 134,979 | — | plan? |
| Jul 13, 2016 SForm 4 → | Jul 14, 5:17 pm EDT | Kevin R SayerPresident & CEO, Director | 7,000 | $79.92 | $559,457 | 342,227 | −2.00% | plan? |
| Jul 11, 2016 SForm 4 → | Jul 12, 6:05 pm EDT | John ListerGeneral Manager, EMEA | 3,560 | $79.35 | $282,494 | 94,334 | −3.64% | plan? |
| Jul 11, 2016 SForm 4 → | Jul 12, 6:05 pm EDT | Jorge A ValdesCTO | 32,000 | $79.36 | $2,539,565 | 91,667 | −25.9% | plan? |
| Jul 11, 2016 MForm 4 → | Jul 12, 6:05 pm EDT | Jorge A ValdesCTO | 32,000 | $7.63 | $244,160 | 123,667 | — | plan? |
| Jul 11, 2016 DForm 4 → | Jul 12, 6:04 pm EDT | Terrance H GreggExecutive Chairman, Director | 2,168 | $79.49 | $172,334 | 468,654 | — | plan? |
| Jun 30, 2016 AForm 4 → | Jul 5, 8:05 pm EDT | John ListerGeneral Manager, EMEA | 32,000 | $0.001 | $32 | 97,894 | — | plan? |
| Jun 29, 2016 SForm 4 → | Jul 1, 5:49 pm EDT | Jeffrey MoySVP, Operations | 4,557 | $80.00 | $364,560 | 50,442 | −8.29% | plan? |
| Jun 29, 2016 SForm 4 → | Jul 1, 5:48 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $78.10 | $390,500 | 129,979 | −3.70% | plan? |
| Jun 29, 2016 MForm 4 → | Jul 1, 5:48 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 5,000 | $3.19 | $15,950 | 134,979 | — | plan? |
| Jun 23, 2016 SForm 4 → | Jun 27, 5:03 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 10,300 | $77.40 | $797,189 | 172,218 | −5.64% | plan? |
| Jun 20, 2016 SForm 4 → | Jun 20, 8:24 pm EDT | Jeffrey MoySVP, Operations | 7,209 | $77.00 | $555,093 | 54,999 | −11.6% | plan? |
| Jun 20, 2016 SForm 4 → | Jun 20, 8:23 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 55,000 | $75.00 | $4,125,000 | 129,979 | −29.7% | plan? |
| Jun 20, 2016 MForm 4 → | Jun 20, 8:23 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 55,000 | $3.19 | $175,450 | 184,979 | — | plan? |
| Jun 20, 2016 SForm 4 → | Jun 20, 8:23 pm EDT | Kevin R SayerPresident & CEO, Director | 35,000 | $75.00 | $2,625,000 | 349,227 | −9.11% | plan? |
| Jun 9, 2016 DForm 4 → | Jun 13, 4:38 pm EDT | Terrance H GreggExecutive Chairman, Director | 2,169 | $73.33 | $159,053 | 470,822 | — | plan? |
| Jun 9, 2016 SForm 4 → | Jun 10, 5:06 pm EDT | Jeffrey MoySVP, Operations | 6,910 | $74.00 | $511,340 | 62,208 | −10.00% | plan? |
| Jun 9, 2016 SForm 4 → | Jun 10, 4:49 pm EDT | John ListerGeneral Manager, EMEA | 3,560 | $73.27 | $260,857 | 65,894 | −5.13% | plan? |
| Jun 9, 2016 MForm 4 → | Jun 10, 4:48 pm EDT | Jorge A ValdesCTO | 10,000 | $7.79 | $77,900 | 101,667 | — | plan? |
| Jun 8, 2016 SForm 4 → | Jun 10, 4:48 pm EDT | Jorge A ValdesCTO | 18,038 | $72.06 | $1,299,807 | 1,550 | −92.1% | plan? |
| Jun 8, 2016 SForm 4 → | Jun 9, 7:00 pm EDT | Jeffrey MoySVP, Operations | 6,866 | $71.00 | $487,486 | 69,118 | −9.04% | plan? |
| Jun 8, 2016 SForm 4 → | Jun 8, 9:18 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 18,239 | $70.88 | $1,292,797 | 182,518 | −9.09% | plan? |
| Jun 7, 2016 SForm 4 → | Jun 8, 8:22 pm EDT | Jess RoperSVP, CFO | 3,471 | $69.00 | $239,500 | 85,248 | −3.91% | plan? |
| Jun 1, 2016 DForm 4 → | Jun 3, 6:14 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 2,650 | $63.51 | $168,304 | 92,250 | — | plan? |
| May 31, 2016 AForm 4 → | Jun 2, 7:52 pm EDT | Donald AbbeyEVP Quality | 55,000 | $0.001 | $55 | 55,000 | — | plan? |
| May 25, 2016 AForm 4 → | May 26, 8:35 pm EDT | Eric TopolDirector | 5,121 | $0.001 | $5 | 9,694 | — | plan? |
| May 25, 2016 AForm 4 → | May 26, 8:31 pm EDT | Jay S SkylerDirector | 5,011 | $0.001 | $5 | 9,486 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 8, 2015 MForm 4 → | May 12, 8:39 pm EDT | John ListerSr. VP, General Counsel | 2,396 | $68.49 | $164,091 | 0 | — | |
| May 7, 2015 MForm 4 → | May 11, 8:08 pm EDT | Terrance H GreggExecutive Chairman, Director | 91,483 | $67.85 | $6,206,811 | 0 | — | |
| May 4, 2015 MForm 4 → | May 5, 8:56 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $67.99 | $509,903 | 20,573 | — | |
| May 4, 2015 MForm 4 → | May 4, 7:58 pm EDT | Terrance H GreggExecutive Chairman, Director | 20,000 | $68.06 | $1,361,276 | 20,000 | — | |
| Apr 27, 2015 MForm 4 → | Apr 29, 8:39 pm EDT | Jeffrey MoySVP, Operations | 5,000 | $69.27 | $346,368 | 0 | — | |
| Apr 23, 2015 MForm 4 → | Apr 27, 5:50 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $69.65 | $522,353 | 28,073 | — | |
| Apr 21, 2015 MForm 4 → | Apr 23, 8:09 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 39,709 | $69.63 | $2,765,008 | 14,000 | — | |
| Apr 20, 2015 MForm 4 → | Apr 22, 7:32 pm EDT | Jess RoperSVP, CFO | 6,000 | $68.06 | $408,340 | 2,827 | — | |
| Apr 10, 2015 MForm 4 → | Apr 14, 6:54 pm EDT | Jeffrey MoySVP, Operations | 15,766 | $66.41 | $1,046,977 | 0 | — | |
| Apr 9, 2015 MForm 4 → | Apr 10, 7:45 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 20,000 | $65.03 | $1,300,511 | 39,709 | — | |
| Apr 9, 2015 MForm 4 → | Apr 10, 7:44 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $64.55 | $484,149 | 35,573 | — | |
| Apr 8, 2015 MForm 4 → | Apr 10, 7:44 pm EDT | Jorge A ValdesCTO | 8,244 | $63.81 | $526,048 | 16,487 | — | |
| Apr 8, 2015 MForm 4 → | Apr 10, 7:41 pm EDT | John ListerSr. VP, General Counsel | 5,039 | $63.84 | $321,680 | 2,396 | — | |
| Mar 25, 2015 MForm 4 → | Mar 27, 4:44 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $61.05 | $457,849 | 43,073 | — | |
| Mar 23, 2015 MForm 4 → | Mar 25, 6:15 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 4,000 | $61.25 | $244,992 | 2,000 | — | |
| Mar 23, 2015 MForm 4 → | Mar 25, 6:07 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 14,000 | $61.33 | $858,680 | 46,508 | — | |
| Mar 18, 2015 MForm 4 → | Mar 20, 5:08 pm EDT | Jess RoperSVP, CFO | 6,000 | $62.44 | $374,657 | 8,827 | — | |
| Mar 12, 2015 MForm 4 → | Mar 13, 8:04 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 20,000 | $59.23 | $1,184,677 | 988 | — | |
| Mar 11, 2015 MForm 4 → | Mar 13, 8:21 pm EDT | Jay S SkylerDirector | 45,000 | $60.01 | $2,700,297 | 0 | — | |
| Mar 11, 2015 MForm 4 → | Mar 13, 8:13 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $58.58 | $439,367 | 50,573 | — | |
| Mar 9, 2015 MForm 4 → | Mar 11, 7:43 pm EDT | Jorge A ValdesCTO | 8,244 | $58.77 | $484,529 | 24,731 | — | |
| Mar 9, 2015 MForm 4 → | Mar 10, 8:55 pm EDT | John ListerSr. VP, General Counsel | 5,039 | $58.77 | $296,156 | 7,435 | — | |
| Mar 2, 2015 MForm 4 → | Mar 4, 6:39 pm EST | Jeffrey MoySVP, Operations | 5,000 | $60.33 | $301,650 | 1,956 | — | |
| Feb 24, 2015 MForm 4 → | Feb 26, 8:44 pm EST | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $62.22 | $466,637 | 58,073 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 6:21 pm EST | Richard DoubledayEVP, Chief Commercial Officer | 4,000 | $63.58 | $254,334 | 6,000 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 6:18 pm EST | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 14,000 | $63.43 | $888,023 | 60,508 | — | |
| Feb 18, 2015 MForm 4 → | Feb 20, 6:00 pm EST | Jess RoperSVP, CFO | 6,000 | $61.89 | $371,341 | 14,827 | — | |
| Feb 17, 2015 MForm 4 → | Feb 19, 5:35 pm EST | Jeffrey MoySVP, Operations | 5,044 | $62.11 | $313,291 | 0 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 7:22 pm EST | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $61.41 | $460,607 | 65,573 | — | |
| Feb 9, 2015 MForm 4 → | Feb 11, 8:06 pm EST | John ListerSr. VP, General Counsel | 5,039 | $61.66 | $310,693 | 12,474 | — | |
| Feb 9, 2015 MForm 4 → | Feb 11, 7:59 pm EST | Jorge A ValdesCTO | 8,244 | $61.67 | $508,380 | 32,975 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 9:18 pm EST | Jeffrey MoySVP, Operations | 5,000 | $60.69 | $303,425 | 5,044 | — | |
| Jan 26, 2015 MForm 4 → | Jan 28, 9:10 pm EST | Andrew K BaloEVP, Clinical, Regulatory & | 15,001 | $59.25 | $888,739 | 0 | — | |
| Jan 23, 2015 MForm 4 → | Jan 27, 7:41 pm EST | Richard DoubledayEVP, Chief Commercial Officer | 4,000 | $58.22 | $232,864 | 10,000 | — | |
| Jan 23, 2015 MForm 4 → | Jan 27, 7:33 pm EST | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 24,532 | $59.67 | $1,463,812 | 9,996 | — | |
| Jan 20, 2015 MForm 4 → | Jan 22, 9:03 pm EST | Jess RoperSVP, CFO | 6,000 | $57.34 | $344,036 | 20,827 | — | |
| Jan 20, 2015 MForm 4 → | Jan 22, 8:54 pm EST | Jeffrey MoySVP, Operations | 5,000 | $57.58 | $287,906 | 10,044 | — | |
| Jan 12, 2015 MForm 4 → | Jan 14, 6:36 pm EST | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 29,468 | $60.16 | $1,772,679 | 20,528 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 8:49 pm EST | Jorge A ValdesCTO | 8,244 | $57.44 | $473,494 | 41,219 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 8:36 pm EST | John ListerSr. VP, General Counsel | 5,039 | $57.42 | $289,337 | 2,452 | — | |
| Jan 5, 2015 MForm 4 → | Jan 7, 5:50 pm EST | Jeffrey MoySVP, Operations | 5,000 | $55.27 | $276,368 | 15,044 | — |